These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34371148)

  • 1. Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics.
    Šoltys M; Zůza D; Boleslavská T; Machač Akhlasová S; Balouch M; Kovačík P; Beránek J; Škalko-Basnet N; Flaten GE; Štěpánek F
    Int J Pharm; 2021 Sep; 607():120982. PubMed ID: 34371148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.
    Zarinwall A; Maurer V; Pierick J; Oldhues VM; Porsiel JC; Finke JH; Garnweitner G
    Drug Deliv; 2022 Dec; 29(1):2086-2099. PubMed ID: 35838584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High loading of lipophilic compounds in mesoporous silica for improved solubility and dissolution performance.
    Benedikt Brenner M; Wüst M; Kuentz M; Wagner KG
    Int J Pharm; 2024 Apr; 654():123946. PubMed ID: 38417728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica.
    Wei Q; Keck CM; Müller RH
    Int J Pharm; 2017 Feb; 518(1-2):253-263. PubMed ID: 27871833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation.
    Price DJ; Nair A; Becker-Baldus J; Glaubitz C; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2020 Jan; 141():105113. PubMed ID: 31655207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
    Baumgartner A; Planinšek O
    Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
    Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
    Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
    He Y; Liang S; Long M; Xu H
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
    Gandhi AV; Thipsay P; Kirthivasan B; Squillante E
    AAPS PharmSciTech; 2017 Nov; 18(8):3140-3150. PubMed ID: 28534299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Loading and Release Study of Vancomycin from a Green Mesoporous Silica.
    Dolete G; Purcăreanu B; Mihaiescu DE; Ficai D; Oprea OC; Bîrcă AC; Chircov C; Vasile BȘ; Vasilievici G; Ficai A; Andronescu E
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.